StockData
Verrica Pharmaceuticals Inc. logo

Verrica Pharmaceuticals Inc. (VRCA) stock

VRCANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$3.14−0.06 (-1.88%)

Close on Nov 17, 2026Market cap $53.94MP/E –Yield –

Verrica Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Verrica Pharmaceuticals's price to book ratio was 15.6× on Nov 11, 2026, against 239.4× a year earlier. Over the last 5 years it ranged from 2.1× to 239.4×, with a median of 5.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202615.6×−169.8
2024Jul 31, 2024185.4×+178.1
2023Dec 29, 20237.3×+4.8
2022Dec 30, 20222.5×−3.6
2021Dec 31, 20216.2×−1.4
2020Dec 31, 20207.6×+1.9
2019Dec 31, 20195.7×+3.5
2018Dec 31, 20182.2×–

More Verrica Pharmaceuticals figures

See a number that looks wrong?